NCT05408897View on ClinicalTrials.gov

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

RecruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2028

Conditions
Gastrointestinal Stromal TumorsMinimal Residual Disease
Interventions
DIAGNOSTIC_TEST

liquid biopsy

A test that enables the diagnosis or analysis of tumors using only a blood or fluid sample rather than a solid tissue biopsy.

Trial Locations (1)

100044

RECRUITING

Peking University People'S Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER